Fig. 3From: Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trialKaplan–Meier plots of OS, EFS and DFS A Overall survival (OS) of all patients. B Event free survival (EFS) of all patients. C disease-free survival (DFS)Back to article page